Pancreatic Polypeptide Family motifs, polypeptides and methods comprising the same

Details for Australian Patent Application No. 2005316524 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Parkes, David; Roth, Jonathan David; D'Souza, Lawrence J.; Ghosh, Soumitra S.; Levy, Odile Esther; Pittner, Richard A.; Prickett, Kathryn S.; Adams, Sean H.; Ahn, John S.; Jodka, Carolyn M.

Agent Spruson & Ferguson

Pub. Number AU-B-2005316524

PCT Pub. Number WO2006/066024

Priority 60/635,897 13.12.04 US; 11/055,098 11.02.05 US; PCT/ US2005/004351 11.02.05 US

Filing date 12 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 12 January 2012

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/066024 Priority application(s): WO2006/066024

19 July 2007 Amendment Made

  The nature of the amendment is: Amend the priority details from PCT/US22000/004351 11 Feb 2005 to PCT/US2005/004351 11 Feb 2005 US 2005318730 Salzgitter Flachstahl GmbH The nature of the amendment is: Amend the name of the co-inventor from Schaperkotter, Markus to Schaeperkoetter, Markus

12 January 2012 Application Accepted

  Published as AU-B-2005316524

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316526-Vertebral column osteosynthesis device comprising a cage, an anterior plate and two longitudinal rods

2005316520-Releasable polymeric conjugates based on aliphatic biodegradable linkers